GLS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Glenmark Life Sciences Ltd

Watchlist Manager

Watchlist

Price: 1 100.6 INR -2.89% Market Closed

Market Cap: ₹134.9B

G	Glenmark Life Sciences Ltd NSE:GLS	IN
	Brightcom Group Ltd NSE:BCG	IN
	Schneider Electric SE OTC:SBGSF	FR
	Cogeco Inc TSX:CGO	CA
	Cadiz Inc NASDAQ:CDZI	US
I	Ishii Iron Works Co Ltd TSE:6362	JP
G	Gruppo MutuiOnline SpA MIL:MOL	IT
	Eni SpA MIL:ENI	IT
	Carlsberg A/S OTC:CABHF	DK
S	Scicom (Msc) Bhd KLSE:SCICOM	MY
	Ikegps Group Ltd NZX:IKE	NZ
N	National Grid PLC XHAM:NNGF	UK
M	Mitsubishi UFJ Financial Group Inc SGX:N5YD	JP

Profitability Summary

Glenmark Life Sciences Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

55%

Gross Margin is Increasing

53% > 55%

Healthy Operating Margin

25%

Sustainable 3Y Average Operating Margin

28%

Declining Operating Margin

28% > 25%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

22% > 19%

Exceptional Free Cash Flow Margin

12%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

7% > 12%

Positive ROE

17%

Positive 3Y Average ROE

Positive 3Y Average ROIC

24%

Declining ROIC

25% > 20%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.